Nanoscale Bacteria-Enabled Autonomous Drug Delivery System (NanoBEADS) Enhances Intratumoral Transport of Nanomedicine

Overview

Journal Adv Sci (Weinh)

Specialty Biomedical Engineering

Date 2019 Feb 19

PMID 30775227

Citations 52

Authors

Seungbeum Suh

Ami Jo

Mahama A Traore

Ying Zhan

Sheryl L Coutermarsh-Ott

Veronica M Ringel-Scaia

Irving C Allen

Richey M Davis

Bahareh Behkam

Affiliations

Soon will be listed here.

Abstract

Cancer drug delivery remains a formidable challenge due to systemic toxicity and inadequate extravascular transport of nanotherapeutics to cells distal from blood vessels. It is hypothesized that, in absence of an external driving force, the serovar Typhimurium could be exploited for autonomous targeted delivery of nanotherapeutics to currently unreachable sites. To test the hypothesis, a nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) is developed in which the functional capabilities of the tumor-targeting . Typhimurium VNP20009 are interfaced with poly(lactic-co-glycolic acid) nanoparticles. The impact of nanoparticle conjugation is evaluated on NanoBEADS' invasion of cancer cells and intratumoral transport in 3D tumor spheroids in vitro, and biodistribution in a mammary tumor model in vivo. It is found that intercellular (between cells) self-replication and translocation are the dominant mechanisms of bacteria intratumoral penetration and that nanoparticle conjugation does not impede bacteria's intratumoral transport performance. Through the development of new transport metrics, it is demonstrated that NanoBEADS enhance nanoparticle retention and distribution in solid tumors by up to a remarkable 100-fold without requiring any externally applied driving force or control input. Such autonomous biohybrid systems could unlock a powerful new paradigm in cancer treatment by improving the therapeutic index of chemotherapeutic drugs and minimizing systemic side effects.

Citing Articles

Advances in micro-/nanorobots for cancer diagnosis and treatment: propulsion mechanisms, early detection, and cancer therapy.

Fu B, Luo D, Li C, Feng Y, Liang W Front Chem. 2025; 13:1537917.

PMID: 39981265 PMC: 11839623. DOI: 10.3389/fchem.2025.1537917.

Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy.

Yan S, Gan Y, Xu H, Piao H Front Bioeng Biotechnol. 2025; 12():1526612.

PMID: 39845371 PMC: 11750792. DOI: 10.3389/fbioe.2024.1526612.

Photosynthetic Bacteria: Light-Responsive Biomaterials for Anti-Tumor Photodynamic Therapy.

Jiang Y Int J Nanomedicine. 2025; 20():465-482.

PMID: 39811429 PMC: 11730521. DOI: 10.2147/IJN.S500314.

Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies.

Shi Z, Li Z, Zhang M J Transl Med. 2024; 22(1):837.

PMID: 39261861 PMC: 11391643. DOI: 10.1186/s12967-024-05640-7.

The application of bacteria-nanomaterial hybrids in antitumor therapy.

Xiao S, Mu M, Feng C, Pan S, Chen N J Nanobiotechnology. 2024; 22(1):536.

PMID: 39227831 PMC: 11373302. DOI: 10.1186/s12951-024-02793-x.

References

Minchinton A, Tannock I . Drug penetration in solid tumours. Nat Rev Cancer. 2006; 6(8):583-92. DOI: 10.1038/nrc1893. View

Francis C, Ryan T, Jones B, Smith S, Falkow S . Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature. 1993; 364(6438):639-42. DOI: 10.1038/364639a0. View

Yoo J, Irvine D, Discher D, Mitragotri S . Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011; 10(7):521-35. DOI: 10.1038/nrd3499. View

Traore M, Sahari A, Behkam B . Construction of Bacteria-Based Cargo Carriers for Targeted Cancer Therapy. Methods Mol Biol. 2018; 1831:25-35. DOI: 10.1007/978-1-4939-8661-3_3. View

Rentsch K, Schwendener R, Pestalozzi B, Sauter C, Wunderli-Allenspach H, Hanseler E . Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancer. Eur J Clin Pharmacol. 1998; 54(1):83-9. DOI: 10.1007/s002280050425. View

Dewhirst M, Secomb T . Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer. 2017; 17(12):738-750. PMC: 6371795. DOI: 10.1038/nrc.2017.93. View

Sahari A, Traore M, Stevens A, Scharf B, Behkam B . Toward development of an autonomous network of bacteria-based delivery systems (BacteriaBots): spatiotemporally high-throughput characterization of bacterial quorum-sensing response. Anal Chem. 2014; 86(23):11489-93. DOI: 10.1021/ac5021003. View

Jain R . Barriers to drug delivery in solid tumors. Sci Am. 1994; 271(1):58-65. DOI: 10.1038/scientificamerican0794-58. View

Felgner S, Kocijancic D, Frahm M, Weiss S . Bacteria in Cancer Therapy: Renaissance of an Old Concept. Int J Microbiol. 2016; 2016:8451728. PMC: 4802035. DOI: 10.1155/2016/8451728. View

10.

M Pawelek J, Low K, Bermudes D . Bacteria as tumour-targeting vectors. Lancet Oncol. 2003; 4(9):548-56. DOI: 10.1016/s1470-2045(03)01194-x. View

11.

Velge P, Wiedemann A, Rosselin M, Abed N, Boumart Z, Chausse A . Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. Microbiologyopen. 2012; 1(3):243-58. PMC: 3496970. DOI: 10.1002/mbo3.28. View

12.

Alexis F, Pridgen E, Molnar L, Farokhzad O . Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5(4):505-15. PMC: 2663893. DOI: 10.1021/mp800051m. View

13.

Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y . Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. 2006; 14(1):68-77. DOI: 10.1038/sj.gt.3302843. View

14.

Jang S, Wientjes M, Lu D, Au J . Drug delivery and transport to solid tumors. Pharm Res. 2003; 20(9):1337-50. DOI: 10.1023/a:1025785505977. View

15.

Kasinskas R, Forbes N . Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res. 2007; 67(7):3201-9. DOI: 10.1158/0008-5472.CAN-06-2618. View

16.

Rosselin M, Virlogeux-Payant I, Roy C, Bottreau E, Sizaret P, Mijouin L . Rck of Salmonella enterica, subspecies enterica serovar enteritidis, mediates zipper-like internalization. Cell Res. 2010; 20(6):647-64. DOI: 10.1038/cr.2010.45. View

17.

Broadway K, Suh S, Behkam B, Scharf B . Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009. J Biotechnol. 2017; 251:76-83. DOI: 10.1016/j.jbiotec.2017.04.006. View

18.

Leaman E, Geuther B, Behkam B . Quantitative Investigation of the Role of Intra-/Intercellular Dynamics in Bacterial Quorum Sensing. ACS Synth Biol. 2018; 7(4):1030-1042. DOI: 10.1021/acssynbio.7b00406. View

19.

Suh S, Jo A, Traore M, Zhan Y, Coutermarsh-Ott S, Ringel-Scaia V . Nanoscale Bacteria-Enabled Autonomous Drug Delivery System (NanoBEADS) Enhances Intratumoral Transport of Nanomedicine. Adv Sci (Weinh). 2019; 6(3):1801309. PMC: 6364498. DOI: 10.1002/advs.201801309. View

20.

Nance E, Zhang C, Shih T, Xu Q, Schuster B, Hanes J . Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano. 2014; 8(10):10655-64. PMC: 4212792. DOI: 10.1021/nn504210g. View